drugset / Trial / NCT06919991

Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)

NCT06919991 ↗

Phase 1 Completed 14 enrolled Arcus Biosciences, Inc.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to assess the effects of multiple doses of itraconazole (a strong CYP3A4 inhibitor) on single dose PK of casdatifan in healthy adults and to assess the effects of multiple doses of phenytoin (a strong CYP3A4 inducer) on single dose PK of casdatifan in healthy adults.

Timeline

Start
2025-05-02
Primary completion
2025-10-18
Completion
2025-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Casdatifan Small molecule — —
Subject Itraconazole Small molecule — —
Subject Phenytoin Unknown — —

Indications

No indication recorded.